Biopharmaceuticals

A biopharmaceutical also called as a biological medical by-product, biologic is other pharmaceutical drug by-product produce in, draw out from, or semisynthesized from biological origin. Distinct from completely synthesized pharmaceuticals, they also contain vaccines, complete blood, blood products, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living drugs used in cell remedy. Biologics can be composed of sugars, proteins, nucleic acids, or compound combinations of these material, or can be living cells or tissues. They (or their precursors or material) are introvert from living origin—human, animal, plant, fungal, or microbial. They may be used in the two human beings and animal treatment.

  • Recombinant Protein Therapy
  • Thrombolytic Agents
  • Haematopoietic Growth Factors
  • Gene Therapy

Related Conference of Biopharmaceuticals

April 10-11, 2025

31st Asia Pacific Biotechnology Congress

Singapore City, Singapore
June 16-17, 2025

28th World Congress on Biotechnology

Amsterdam, Netherlands
June 23-24, 2025

28th European Biotechnology Congress

Paris, France
September 15-16, 2025

29th Global Congress on Biotechnology

Aix-en-Provence, France
December 04-05, 2025

9th International Conference on Protein Engineering

Paris, France
December 11-12, 2025

7th International Conference on Biochemistry

Prague, Czech Republic

Biopharmaceuticals Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in